• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Sabre Are Trading Lower By 19%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    2/15/23 2:04:29 PM ET
    $ABNB
    $ABST
    $AKAM
    $AMST
    Diversified Commercial Services
    Consumer Discretionary
    Real Estate
    Real Estate
    Get the next $ABNB alert in real time by email

    Gainers

    • Sera Prognostics, Inc. (NASDAQ:SERA) shares surged 63.4% to $2.11 after the company announced top-line data from the AVERT PRETERM TRIAL.
    • TransCode Therapeutics, Inc. (NASDAQ:RNAZ) shares climbed 63.4% to $0.7684 after the company requested the withdrawal of a registration statement, saying it has determined not to pursue the sale of securities at this time.
    • Tenon Medical, Inc. (NASDAQ:TNON) rose 36.4% to $1.3513 after dropping 10% on Tuesday. Tenon Medical, during November, posted a Q3 loss of $0.28 per share.
    • Vallon Pharmaceuticals, Inc. (NASDAQ:VLON) shares rose 34.6% to $0.8771 after dropping 26% on Tuesday. Vallon Pharmaceuticals and GRI Bio recently announced they entered into a merger agreement.
    • Titan Medical Inc. (NASDAQ:TMDI) jumped 33.8% to $0.18. The Nasdaq recently notified Titan Medical regarding Audit Committee requirements.
    • Roblox Corporation (NYSE:RBLX) shares climbed 24.8% to $44.54 after the company reported better-than-expected Q4 sales results.
    • NerdWallet, Inc. (NASDAQ:NRDS) surged 22% to $17.40 following strong quarterly results.
    • Cerberus Cyber Sentinel Corporation (NASDAQ:CISO) jumped 21% to $0.9300. Cerberus Sentinel recently announced a proposed public offering of common stock.
    • Upstart Holdings, Inc. (NASDAQ:UPST) gained 20.6% to $20.34 after the company reported better-than-expected financial results but issued weak guidance.
    • The Trade Desk, Inc. (NASDAQ:TTD) gained 19.4% to $59.76 after the company reported better-than-expected Q4 adjusted results and issued Q1 revenue guidance above estimates. The company also announced a $700 million buyback.
    • Atlis Motor Vehicles, Inc. (NASDAQ:AMV) jumped 20% to $1.86.
    • Sidus Space, Inc. (NASDAQ:SIDU) gained 16% to $0.6778 after the company announced a $2.5 million agreement with the Netherlands for laser communication satellite.
    • Humanigen, Inc. (NASDAQ:HGEN) rose 15.3% to $0.2075. Humanigen received a notice of allowance for its U.S. patent application 16/652,977 titled "Methods of Treating Immunotherapy-Related Toxicity Using a GM-CSF Antagonist."
    • Vapotherm, Inc. (NYSE:VAPO) jumped 15% to $1.07. Vapotherm VP, Controller and CAO Dorota McKay acquired a total of 19,047 shares at an average price of $1.05.
    • Digital Ally, Inc. (NASDAQ:DGLY) shares rose 13.3% to $4.59. Digital Ally sought withdrawal of the registration from the U.S. SEC. The company no longer wished to conduct a public offering of its securities.
    • Airbnb, Inc. (NASDAQ:ABNB) rose 11.8% to $135.25 after the company reported strong earnings and sales results for its fourth quarter and issued strong Q1 sales forecast.
    • Herbalife Nutrition Ltd. (NYSE:HLF) surged 11.8% to $19.43 following upbeat Q4 results.
    • OraSure Technologies, Inc. (NASDAQ:OSUR) gained 10.5% to $5.41 after the company reported better-than-expected Q4 sales results. The company also issued Q1 2023 revenue guidance above estimates.
    • Healthcare Services Group, Inc. (NASDAQ:HCSG) rose 10.2% to $13.94 following upbeat Q4 results.
    • Pagaya Technologies Ltd. (NASDAQ:PGY) jumped 9.6% to $1.4694 after the company reported better-than-expected Q4 adjusted EPS and sales results.
    • Nano Dimension Ltd. (NASDAQ:NNDM) gained 9.3% to $2.8750. Nano Dimension initiated an active share repurchase process allowing the company to invest up to $100 million to repurchase its American Depository Shares.
    • BioSig Technologies, Inc. (NASDAQ:BSGM) rose 7.4% to $1.2910 after dropping 12% on Tuesday. BioSig Technologies reported the retirement of chief financial officer Steve Chaussy and named Steve Buhaly as his successor.

    Losers

    • GlycoMimetics, Inc. (NASDAQ:GLYC) shares dipped 55.2% to $1.8150. GlycoMimetics reported continuation of Phase 3 study of e-selectin antagonist uproleselan in relapsed/refractory aml to originally planned final analysis following interim analysis by the independent Data Monitoring Committee.
    • Credo Technology Group Holding Ltd (NASDAQ:CRDO) shares dipped 47.2% to $10.22 after the company issued Q4 revenue guidance below analyst estimates.
    • T2 Biosystems, Inc. (NASDAQ:TTOO) shares dropped 22% to $0.8405 after the company priced an 11.11 million share common stock offering at $1.08 per share.
    • Great Lakes Dredge & Dock Corporation (NASDAQ:GLDD) fell 21% to $5.32 following Q4 results.
    • iPower Inc. (NASDAQ:IPW) fell 20.6% to $0.73 after the company reported worse-than-expected Q2 EPS and sales results.
    • Amesite Inc. (NASDAQ:AMST) dropped 18.8% to $0.4137. Amesite recently announced GPT-3 powered functionality to its AI toolkit for customers and users.
    • Sabre Corporation (NASDAQ:SABR) dropped 18.7% to $5.60 after the company reported worse-than-expected Q4 adjusted EPS and sales results and issued guidance.
    • Amesite Inc. (NASDAQ:AMST) fell 17.6% to $0.4201. Amesite shares jumped around 82% on Tuesday after the company announced GPT-3 powered functionality to its AI toolkit for customers and users.
    • Sunlands Technology Group (NYSE:STG) dropped 17.2% to $10.77.
    • Reed's, Inc. (NASDAQ:REED) fell 17.2% to $2.84 after the company announced it will transition from the Nasdaq Capital Market to the OTCQX.
    • AMMO, Inc. (NASDAQ:POWW) fell 16.9% to $1.87 after reporting downbeat Q3 sales.
    • Absolute Software Corporation (NASDAQ:ABST) fell 16.2% to $9.55 following weak Q2 results.
    • Harpoon Therapeutics, Inc. (NASDAQ:HARP) dropped 15.3% to $0.8301.
    • ContraFect Corporation (NASDAQ:CFRX) fell 14.2% to $4.3250.
    • Entrada Therapeutics, Inc. (NASDAQ:TRDA) dropped 13.9% to $11.22.
    • Blue Water Vaccines, Inc. (NASDAQ:BWV) shares fell 12.8% to $1.36. Blue Water Vaccines shares jumped 33% on Tuesday after a 13G filing showed Joseph Hernandez report an 18.43% passive stake in the company.
    • Devon Energy Corporation (NYSE:DVN) dropped 11.2% to $56.79 after the company posted downbeat Q4 results.
    • Hecla Mining Company (NYSE:HL) fell 10.5% to $5.06 following Q4 results.
    • Akamai Technologies, Inc. (NASDAQ:AKAM) dropped 10% to $79.06 after the company reported Q4 financial
    • results. Following earnings, RBC Capital downgraded the stock from Outperform to Sector Perform and announced an $85 price target.
    • Hempacco Co., Inc. (NASDAQ:HPCO) fell 10% to $1.35. Hempacco reported closing of upsized $7.245 million public offering including full exercise of over-allotment option.
    • Barclays PLC (NYSE:BCS) tumbled 9.2% to $8.37 after the company reported a 14% decline in annual profits.
    • Ouster, Inc. (NYSE:OUST) shares fell 9.1% to $1.50 after gaining 20% on Tuesday. Ouster is scheduled to report its financial results for the fourth quarter after the market closes on March 23, 2023.
    • Athenex, Inc. (NASDAQ:ATNX) fell 9% to $3.1999.
    • ImmunityBio, Inc. (NASDAQ:IBRX) dropped 8% to $3.44. ImmunityBio announced execution of $50 million equity financing with multiple institutional investors.
    • Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) shares dropped 6.2% to $91.85 after Berkshire Hathaway disclosed it cut its stake in the company by 86.2%.
    • Mullen Automotive, Inc. (NASDAQ:MULN) shares declined 6.2% to $0.3530. Mullen Automotive filed for mixed-securities shelf offering.
    • Mercury General Corporation (NYSE:MCY) fell 5% to $35.33 following Q4 results.

    Now Read This: Bitcoin Rises Above This Key Level; ImmutableX Among Top Gainers

    Get the next $ABNB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABNB
    $ABST
    $AKAM
    $AMST

    CompanyDatePrice TargetRatingAnalyst
    NerdWallet Inc.
    $NRDS
    3/13/2026Equal-Weight → Underweight
    Morgan Stanley
    ImmunityBio Inc.
    $IBRX
    3/12/2026$13.00Buy
    BTIG Research
    The Trade Desk Inc.
    $TTD
    3/6/2026$23.00Neutral → Underperform
    Wedbush
    Barclays PLC
    $BCS
    3/5/2026Buy → Hold
    Erste Group
    Roblox Corporation
    $RBLX
    3/4/2026$65.00Neutral
    DA Davidson
    Healthcare Services Group Inc.
    $HCSG
    3/3/2026$22.00Sector Perform
    RBC Capital Mkts
    Sabre Corporation
    $SABR
    3/3/2026$1.50Outperform → Mkt Perform
    Bernstein
    The Trade Desk Inc.
    $TTD
    2/26/2026$17.00Neutral → Sell
    New Street
    More analyst ratings

    $ABNB
    $ABST
    $AKAM
    $AMST
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    NerdWallet downgraded by Morgan Stanley

    Morgan Stanley downgraded NerdWallet from Equal-Weight to Underweight

    3/13/26 8:45:52 AM ET
    $NRDS
    EDP Services
    Technology

    BTIG Research resumed coverage on ImmunityBio with a new price target

    BTIG Research resumed coverage of ImmunityBio with a rating of Buy and set a new price target of $13.00

    3/12/26 8:52:16 AM ET
    $IBRX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    The Trade Desk downgraded by Wedbush with a new price target

    Wedbush downgraded The Trade Desk from Neutral to Underperform and set a new price target of $23.00

    3/6/26 8:26:23 AM ET
    $TTD
    Computer Software: Programming Data Processing
    Technology

    $ABNB
    $ABST
    $AKAM
    $AMST
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    ImmunityBio Achieves Milestone with Large-Scale NK Cell Production and Cryopreservation from Over 60 Healthy and Cancer Donors

    Methods developed and validated to establish the "World Bank of NK Cells" from healthy donors and cancer patients Single apheresis yields up to 5 billion (5×109) highly pure activated memory cytokine-enhanced NK cells (M-ceNK), providing up to 8-10 doses of M-ceNK product per patient Manufacturing and cryo-banking process established with finished dosage form of M-ceNK cells available within 12 days from apheresis M-ceNK cells successfully cryopreserved with demonstration of retained cytotoxicity against multiple tumor cell lines Methods now established in readiness for manufacturing in AI-driven automated robotic systems (NANT Leonardo) Combination of M-ceNK with ANKTIVA® s

    3/13/26 7:30:00 AM ET
    $IBRX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Digital Convergence Technologies (DCT) Joins Akamai Partner Connect Program

    CAMBRIDGE, Mass., March 13, 2026 (GLOBE NEWSWIRE) -- Akamai (NASDAQ:AKAM) today announced Digital Convergence Technologies (DCT), a system integration and digital transformation company that simplifies complex IT challenges through its "converge and deliver" philosophy, has joined the Akamai Partner Connect Program. DCT enables mid-market and enterprise clients to leverage a specialized refactoring practice for migrating workloads to Akamai, providing a streamlined, cost-effective path to cloud modernization that was previously fragmented across multiple vendors. DCT's key services and offerings include system and cloud engineering, architecture modernization, and large-scale refactoring

    3/13/26 6:35:00 AM ET
    $AKAM
    Real Estate

    4,000+ Deaths; New Rules; What California Drivers Need to Know About 2026 Road Laws

    New laws expand roadside safety rules, strengthen consumer protections and modernize DMV processesLOS ANGELES, March 12, 2026 /PRNewswire/ -- Several new California driving laws took effect January 1, 2026, aimed at improving roadway safety, strengthening consumer protections and modernizing Department of Motor Vehicles processes. According to Mercury Insurance, the new legislation reflects how driving is evolving in California — from increased roadside risks to emerging vehicle technologies — and underscores the importance of drivers staying informed about changes that could affect daily driving habits."These new laws reflect how quickly driving conditions, vehicle technology and enforcemen

    3/12/26 12:00:00 PM ET
    $MCY
    Property-Casualty Insurers
    Finance

    $ABNB
    $ABST
    $AKAM
    $AMST
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for FAMOTIDINE issued to ATHENEX INC

    Submission status for ATHENEX INC's drug FAMOTIDINE (SUPPL-13) with active ingredient FAMOTIDINE has changed to 'Approval' on 01/07/2022. Application Category: ANDA, Application Number: 075684, Application Classification: Labeling

    1/12/22 4:41:30 AM ET
    $ATNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for KLISYRI

    Submission status for ATHENEX INC's drug KLISYRI (ORIG-1) with active ingredient TIRBANIBULIN has changed to 'Approval' on 12/14/2020. Application Category: NDA, Application Number: 213189, Application Classification: Type 1 - New Molecular Entity

    12/20/20 4:30:55 PM ET
    $ATNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABNB
    $ABST
    $AKAM
    $AMST
    SEC Filings

    View All

    Amendment: SEC Form SC 14D9/A filed by Great Lakes Dredge & Dock Corporation

    SC 14D9/A - Great Lakes Dredge & Dock CORP (0001372020) (Subject)

    3/13/26 4:35:44 PM ET
    $GLDD
    Military/Government/Technical
    Industrials

    SEC Form 144 filed by Sera Prognostics Inc.

    144 - SERA PROGNOSTICS, INC. (0001534969) (Subject)

    3/12/26 8:08:27 PM ET
    $SERA
    Medical Specialities
    Health Care

    SEC Form FWP filed by Airbnb Inc.

    FWP - Airbnb, Inc. (0001559720) (Subject)

    3/12/26 5:18:52 PM ET
    $ABNB
    Diversified Commercial Services
    Consumer Discretionary

    $ABNB
    $ABST
    $AKAM
    $AMST
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Lindgardt Zhenya was granted 154,440 shares, increasing direct ownership by 21% to 892,754 units (SEC Form 4)

    4 - SERA PROGNOSTICS, INC. (0001534969) (Issuer)

    3/13/26 6:28:36 PM ET
    $SERA
    Medical Specialities
    Health Care

    General Counsel Jackson Benjamin was granted 44,215 shares, increasing direct ownership by 39% to 158,935 units (SEC Form 4)

    4 - SERA PROGNOSTICS, INC. (0001534969) (Issuer)

    3/13/26 6:28:19 PM ET
    $SERA
    Medical Specialities
    Health Care

    Chief Medical Officer Inglis Tiffany Eul Davis was granted 17,437 shares, increasing direct ownership by 23% to 92,437 units (SEC Form 4)

    4 - SERA PROGNOSTICS, INC. (0001534969) (Issuer)

    3/13/26 6:28:00 PM ET
    $SERA
    Medical Specialities
    Health Care

    $ABNB
    $ABST
    $AKAM
    $AMST
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Boulet Virginia bought $136,175 worth of shares (6,500 units at $20.95), increasing direct ownership by 3% to 228,342 units (SEC Form 4)

    4 - Ouster, Inc. (0001816581) (Issuer)

    3/9/26 7:35:06 PM ET
    $OUST
    Industrial Machinery/Components
    Industrials

    President and CEO Green Jeffrey Terry was granted 398,089 shares and bought $148,101,266 worth of Class A Common Stock (6,000,000 units at $24.68), increasing direct ownership by 154% to 655,917 units (SEC Form 4)

    4 - Trade Desk, Inc. (0001671933) (Issuer)

    3/4/26 8:27:33 PM ET
    $TTD
    Computer Software: Programming Data Processing
    Technology

    Large owner Constellation Software Inc bought $12,341,572 worth of shares (10,634,702 units at $1.16) (SEC Form 4)

    4 - Sabre Corp (0001597033) (Issuer)

    3/3/26 5:32:25 PM ET
    $SABR
    Computer Software: Programming Data Processing
    Technology

    $ABNB
    $ABST
    $AKAM
    $AMST
    Financials

    Live finance-specific insights

    View All

    Reed's Schedules Fourth Quarter & Full Year 2025 Conference Call for March 25 at 8:30 a.m. ET

    NORWALK, Conn., March 11, 2026 (GLOBE NEWSWIRE) -- Reed's, Inc. (NYSE:REED) ("Reed's" or the "Company"), owner of the nation's leading portfolio of handcrafted, natural ginger beverages, will host a conference call on Wednesday, March 25, 2026, at 8:30 a.m. Eastern time to discuss its financial results for the three and twelve months ended December 31, 2025. The Company's results will be reported in a press release prior to the call. Reed's management will host the conference call, followed by a question-and-answer period. Date: Wednesday, March 25, 2026Time: 8:30 a.m. Eastern timeToll-free dial-in number: (800) 717-1738International dial-in number: (646) 307-1865Conference ID: 59633Webc

    3/11/26 4:30:00 PM ET
    $REED

    Next-Generation Platforms Scale Across Energy, Wellness, and Smokeless Consumer Segments

    Issued on behalf of Doseology Sciences Inc.Equity-Insider.com VANCOUVER, BC, March 5, 2026 /CNW/ -- Consumers are voting with their wallets, and zero-sugar is winning. Zero-sugar beverages are driving 6x more dollar growth than regular varieties as buyers actively choose clean-label products with natural sweeteners and functional ingredients[1]. The global market is forecast to expand from $350 billion in 2024 toward $500 billion by 2029, fueled by health-conscious consumers who want naturally functional products without heavy processing[1]. This structural shift is creating validated demand for precision-dosed, portable formats across energy and wellness categories, positioning Doseology Sc

    3/5/26 9:00:00 AM ET
    $HLF
    $NHTC
    $NMTC
    Other Pharmaceuticals
    Health Care
    Consumer Specialties
    Consumer Discretionary

    Akamai Discloses Technical Details on AI Cluster Deal

    CAMBRIDGE, Mass., March 05, 2026 (GLOBE NEWSWIRE) -- Akamai Technologies, Inc. (NASDAQ:AKAM) has provided additional detail on the recent four-year, $200 million service agreement it signed with a major U.S. tech company at the forefront of the AI revolution for high-performance AI compute. Under the terms of the deal, the customer will utilize a multi-thousand NVIDIA® Blackwell GPU cluster hosted in a data center designed for efficient, high-density power capacity, as well as other cloud infrastructure services on Akamai's distributed cloud platform. The deal underscores enterprise demand for Akamai's integrated AI development and deployment platform and represents one of the world's lar

    3/5/26 6:30:00 AM ET
    $AKAM
    Real Estate

    $ABNB
    $ABST
    $AKAM
    $AMST
    Leadership Updates

    Live Leadership Updates

    View All

    Sabre Appoints Niklas Andréen as Chief Commercial Officer, Airline Tech

    New leadership role underscores Sabre's commitment to accelerating airline growth and innovation following its AI-native platform rebuild SOUTHLAKE, Texas, March 10, 2026 /PRNewswire/ -- Sabre (NASDAQ:SABR) today announced the appointment of Niklas Andréen as Chief Commercial Officer, Airline Tech, a role intended to accelerate execution following the company's once-in-a-generation technology rebuild. The appointment reflects growing momentum across Sabre's airline business as customers increasingly adopt modern retailing technology that moves them into the new world of offer-or

    3/10/26 9:00:00 AM ET
    $SABR
    Computer Software: Programming Data Processing
    Technology

    Sabre and Constellation Software Enter into Strategic Governance Agreement

    Sabre Appoints Damian McKay to Board of Directors as a Representative of ConstellationSOUTHLAKE, Texas and TORONTO, March 5, 2026 /PRNewswire/ -- Sabre Corporation (NASDAQ:SABR) ("Sabre" or the "Company"), a leading global travel technology company, and Constellation Software Inc. (TSX:CSU) ("Constellation"), a global, diversified technology provider that manages and builds vertical market software businesses and a beneficial owner of approximately 12.7% of Sabre's outstanding shares, today announced that following constructive discussions, the companies have entered into a strategic governance agreement. In connection with the agreement, Sabre will appoint Damian McKay, Chief Executive Offi

    3/5/26 5:17:00 PM ET
    $SABR
    Computer Software: Programming Data Processing
    Technology

    The Trade Desk Introduces the Ventura Ecosystem to Advance the Future of CTV Advertising; V and Nexxen Join as the First Collaborators

    The Ventura Ecosystem aims to unite global TV operating systems and industry partners to create a more transparent, collaborative, and revenue-optimized marketplace for CTV advertising Today, The Trade Desk's Ventura, the platform built for a fairer and more transparent streaming ecosystem, takes the next step in its vision to optimize programmatic advertising in connected TV (CTV) with the launch of the Ventura Ecosystem. The Ventura Ecosystem is an industry collaboration that brings global TV operating systems and streaming platforms together to create a more transparent and revenue‑optimized marketplace, so the industry can continue to grow and thrive. Through the Ventura Ecosystem, pa

    2/24/26 9:00:00 AM ET
    $TTD
    Computer Software: Programming Data Processing
    Technology

    $ABNB
    $ABST
    $AKAM
    $AMST
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Reeds Inc.

    SC 13D/A - REED'S, INC. (0001140215) (Subject)

    12/6/24 4:30:32 PM ET
    $REED

    Amendment: SEC Form SC 13D/A filed by Reeds Inc.

    SC 13D/A - REED'S, INC. (0001140215) (Subject)

    12/4/24 6:11:30 AM ET
    $REED

    SEC Form SC 13G filed by GlycoMimetics Inc.

    SC 13G - GLYCOMIMETICS INC (0001253689) (Subject)

    11/27/24 2:22:44 PM ET
    $GLYC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABNB
    $ABST
    $AKAM
    $AMST
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    What Does the Recent Purchase at GlycoMimetics Inc. on Jun 20 Indicate?

    Recently, on June 20, 2024, an insider purchase was made at GlycoMimetics Inc., grabbing the attention of investors. According to the SEC Form 4 filing, SVP Finance, CFO Hahn Brian M. bought $4,335 worth of shares (17,500 units at $0.25), boosting direct ownership by 33% to 70,643 units. Insider transactions are closely monitored by investors as they can provide insights into the company's prospects and the confidence of insiders in the business. Let's delve deeper into the recent insider purchase and analyze any potential patterns or significance in comparison to other insider transactions at GlycoMimetics Inc. In early April 2024, Goldberg Mark Alan was granted 4,584 shares, augmenting di

    6/20/24 6:20:00 PM ET
    $GLYC
    Biotechnology: Pharmaceutical Preparations
    Health Care